Osa-phasi01g0932


Function Link


Basic Info

Source:

XM_015765976.2

Strand on PHAS Transcript:

-

Start on PHAS Transcript:

2327

Sequence:

UUGAGUGCAGUUUUCUUUGAC

Length:

21

PHAS Gene Name:

LOC4324864

Chr:

Chr1

PHAS Transcript Annotation:

endoribonuclease Dicer homolog 3a-like

PHAS Transcript Sequence:

AAUUAGGAAAUUACCCUCGCCAUUUUGACGUAGUGGCCUCUGUCGUCCGUGAGUUACCCUGACCCCUCCUCGUCAGUUUGCCCGCCGCGGCGCCGCCGCCGCCGCCGCCGAUCCCCAUCCAUCCCGCGAGCGAGCAGGGCGCCGUCGUUCGUCCUGCUGCAUCCGCCGCAUCCUGUAAACAUGAACCCUUUAAAGAGGUCAUUGGAAUCAUCUUCUCAGGAACAUGAAGCAGGCAAACAGAAACUGCAGAAGAGAGAGUGUCAAGAUUUCACUCCCAGAAGAUAUCAGCUUGAUGUCUAUGAGGUUGCAAUGCGGAGAAACACGAUUGCGAUGCUUGACACAGGAGCCGGGAAGACAAUGAUUGCUGUGAUGCUUAUCAAGGAGUUCGGAAAGAUAAACAGAACAAAGAAUGCUGGAAAAGUCAUCAUAUUUCUUGCACCAACAGUUCAACUUGUUACACAGCAAUGCGAGGUGAUUGAAAUCCACACAGAUUUUGAGGUAGAACAAUACUAUGGUGCAAAGGGGGUUGAUCAAUGGACAGGUCCUAGAUGGCAAGAGCAAAUCUCAAAAUACCAGGUCAUGGUCAUGACACCACAGGUGUUCCUACAAGCUUUACGCAAUGCUUUCUUAAUCUUGGACAUGGUUAGUCUCAUGAUAUUUGAUGAAUGCCAUCAUGCAACUGGAAACCACCCUUAUACAAGAAUAAUGAAGGAGUUCUAUCACAAAUCAGAACAUAAGCCAAGUGUGUUUGGUAUGACAGCAUCACCUGUUAUAAGAAAAGGUAUCUCUUCUCAUUUGGAUUGUGAAGGUCAGUUCUGUGAAUUGGAGAACCUGUUAGAUGCUAAGAUCUACACAGUUUCAGAUAGAGAAGAGAUAGAGUUUUGUGUUCCUUCUGCAAAAGAAAUGUGCAGGUACUAUGACUCGAAACCAGUUUGUUUUGAAGAUUUGAGUGAAGAAUUGGGAGUUUUAUGUUCCAAGUAUGAUGCAUUGAUAACAGAGUUGCAGAAUAAGCGAAGCGACAUGUAUAAAGAUGCUGAUGAUAUAACAAAAGAAUCAAAGAGACGCCUUUCUAAAUCUAUAGCAAAAAUUUGCUACUGCCUUGAUGAUGUUGGUCUUAUUUGUGCAAGUGAGGCCACAAAAAUCUGCAUUGAAAGGGGCCAGGAGAAAGGUUGGCUGAAGGAAGUAGUUGAUGCCACAGAUCAGCAAACUGAUGCAAAUGGAUCACGCCUAUUUGCAGAAAAUUCAGCGCUUCAUAUGAAGUUCUUUGAGGAAGCCUUGCAUUUAAUUGACAAACGCCUCCAACAAGGUAUCGACAUGCUUCUAAACUCAGAAAGUGGAUGUGUUGAAGCAGCAAAGACGGGCUAUAUUUCCCCAAAGCUCUAUGAACUCAUCCAGAUCUUUCACUCUUUUAGUAACUCUCGUCAUGCUCGAUGCCUCAUUUUUGUUGAUCGAAAGAUCACUGCUAGAGUCAUUGACCGGAUGAUUAAGAAAAUUGGCCACCUUGCACAUUUCACAGUUUCUUUUCUUACUGGAGGGAGAUCUUCGGUGGAUGCUCUGACACCCAAAAUGCAGAAGGAUACAUUGGAUUCAUUUCGCUCUGGAAAGGUGAACUUACUAUUUACUACAGAUGUUGCUGAAGAGGGUAUCCAUGUCCCAGAAUGCUCUUGUGUAAUACGAUUUGAUUUGCCAAGGACAACACGUAGCUAUGUGCAGUCACGUGGACGAGCACGCCAGGAAGACUCUCAGUACAUUCUCAUGAUUGAACGGGGGAACGUGAAGCAAAAUGAUUUGAUAUCUGCAAUUGUGAGAAGUGAGACUUCAAUGGUUAAGAUUGCUUCAAGCAGAGAGUCUGGAAAUCUGUCGCCUGGUUUUGUUCCCAAUGAAGAAAUAAACGAAUACCAUGUAGGCACAACAGGAGCGAAAGUAACUGCUGAUUCAAGCAUCAGUAUUGUCUACCGAUACUGUGAGAAGCUUCCGCAGGAUAAGUGCUACUCCCCAAAACCUACAUUUGAGUUCACUCAUCAUGAUGAUGGAUAUGUGUGUACAUUAGCAUUACCACCAAGUGCUGUGCUUCAAAUUCUGGUGGGCCCAAAAGCAAGAAACAUGCACAAAGCAAAACAGCUCGUUUGCCUUGAUGCAUGUAAGAAGUUGCAUGAGCUAGGAGCACUUGAUGACCACCUUUGUCUAUCUGUUGAAGAUCCAGUUCCAGAAAUUGUAAGCAAAAAUAAGGGUACUGGUAUAGGUACAACCAAACGGAAGGAGCUACAUGGUACAACAAGAAUUCAUGCUUGGUCUGGCAAUUGGGUGUCAAAGAAAACUGCACUCAAUUGAGUGCAGUUUUCUUUGACUUUUGUUUGUGACCAAGCUGGUCAGAUUUACUCUGAAUUUGUUCUGUUAAUUGAUGCAACUUUACCGGAUGAAGUCGCUACUUUGGAGAUUGACCUAUAUUUGCACGACAAGAUGGUCAAAACUUCAGUUUCUUCUUGUGGACUUCUUGAGUUGGAUGCUCAACAGAUGGAACAAGCAAAGUUGUUUCAAGGGCUUCUCUUCAAUGGUUUGUUUGGAAAGCUGUUUACUAGAUCAAAAGUACCUAAUGCUCCGAGGGAAUUCAUUCUUAAUAAAGAGGAUACAUUUGUGUGGAACACUGCGAGUGUAUAUUUGCUUUUACCAACAAAUCCUUCUUUUGACUCCAACGUUUGUAUUAAUUGGAGUGUCAUUGAUGCGGCAGCUACGGCAGUUAAACUUAUGAGAAGGAUUUAUUCUGAGAAUAAAAGAGAAUUACUUGGAAUAUUUGAUUCUGACCAAAAUGUUGGAGAUUUAAUUCAUUUAGCUAACAAGUCGUGUAAGGCUAACAGCCUCAAAGAUAUGGUAGUUCUAGCAGUUCACACUGGGAAGAUAUAUACUGCUCUUGAUAUUACUGAAUUAUCUGGCGAUAGCGCUUUUGAUGGUGCAUCUGAUAAGAAAGAAUGUAAAUUCCGGACAUUCGCAGAAUAUUUCAAAAAGAAGUAUGGCAUAGUACUUCGCCACCCCUCACAGCCACUACUAGUUUUGAAGCCUAGUCAUAAUCCUCACAACCUUCUUUCCUCGAAGUUCAGGGAUGAAGGUAAUGUUGUGGAGAAUAUGAGUAAUGGCACACCAGUUGUAAAUAAAACAAGCAACCGUGUCCACAUGCCUCCUGAGUUGCUGAUUCCCCUUGAUUUACCUGUGGAAAUUUUGAGAUCAUUCUAUUUGUUUCCGGCUUUGAUGUAUCGGAUUGAGUCAUUAACGUUAGCUAGUCAACUAAGAAGUGAAAUUGGAUACAGCGAUUCUAAUAUAUCAAGUUUCCUGAUUCUGGAAGCUAUUACAACGCUUAGGUGCUCUGAGGAUUUCUCUAUGGAGCGUCUAGAAUUAUUGGGAGACUCUGUAUUGAAGUAUGCAGUGAGUUGUCAUCUUUUCCUGAAAUUUCCUAAUAAGGAUGAGGGGCAGCUAUCAUCCAUAAGGUGCCAUAUGAUUUGUAAUGCCACACUUUAUAAGCUUGGAAUUGAACGCAAUGUACAGGGUUACGUACGUGAUGCUGCAUUUGAUCCUCGUCGAUGGCUAGCACCAGGACAGCUCUCUAUUCGUCCAUCUCCUUGUGAAUGCCCUGUAAAAUCUGAGGUUGUAACUGACGAUAUUCAUAUCAUUGAUGACAAGGCUAUUGUUCUAGGCAAGGCGUGUGACAAGGGACACAGAUGGAUGUGUUCCAAAACCAUUGCUGAUUGUGUUGAGGCUAUUAUUGGGGCAUAUUAUGCAGGGGGUGGUUUAAGAGCAGCCAUGGCAGUUCUCAAAUGGUUGGGCAUCGGGGCUGAAAUUGAAGAAGACUUGAUUGUGCAGGCCAUAUUGAGUGCUUCUGUGCAGACUUAUCUUCCAAAAGACAAUGUAUUUGAAAUGCUUGAAGCAAAACUAGGCUAUUCUUUCUCGGUGAAAGGUCUUUUGGUAGAGGCUCUGACUCACCCAUCACAGCAGGAGUUAGGUGCAAAAUACUGCUACGAGCGCCUAGAGUUCCUCGGUGAUGCGGUCUUAGACAUUCUGUUAACAAGAUAUCUUUUCAAUAGUCAUAAAGACACUAAUGAGGGGGAGUUGACAGACUUACGUUCUGCAUCAGUCAAUAAUGAAAACUUUGCACAAGUUGCAGUAAAGCACAACUUCCAUCACUUUCUCCAGCAUUCUUCUGGGCUUCUGUUAGACCAAAUUACUGAAUAUGUGAAUAGGUUGGAAGGUUCAUCCAUGGACAAAGUUGAACUGUUAUCAGAUGGACUCCCAAAAGGGCCUAAAGUCCUUGGUGAUAUUGUAGAAAGUAUUGCAGGUGCAAUUCUUUUAGACACCAAACUUGAUUUGGAUGUAGUCUGGGGUAUUUUUGAACCCCUUCUUUCCCCAAUUGUCACACCUGAGAAUCUGGAGUUACCUCCAUACAGAGAGCUUAUCGAAUGGUGUGGCAAACAUGGGUAUUUUGUAGGAAUUAACUGUAGAGAUCAAGGAGACACAGUAGUGGCUACUCUUGAUGUACAGCUCAAAGAGGUGCUUCUUGUGAGGCAAGGUUUUAGCAAGAAAAGAAAAGAUGCGAAAGCGCAUGCAUCUUCCUUACUGCUCAAAGAUCUCGAGGAAAAAGGACUAAUAAUCCCAAAGAAUGCAAGCAAGACAGAACAAUUUGAAAAGCAUUGUGGCAGCACUAAUCCCUUCAACAAUUUGCAUGUCGAUGCAAUGGAUACACAGACUCCAAAACCAACCAAGGAAAAAAACGCAGCUGAUUCAAGGAACAUUUCUGAUCCCCUGCUUGGUAAACCAUUGCACGUGAUUGUGAAAACGAGUAAAGGAGGACCACGCAUUGCAUUAUAUGAGUUGUGUAAAAAGUUGCAAUGGCCAAUGCCUACAAUGGAAUCUGAGAAAGUACAACCAAGCUUUAGCAGCGUGUGCUCCUCCCCUGGUGGUUCCUCUCAGAAAGCUACCCCCCAAGCGUUCGCUUUCGCUUCAACCAUUACAUUGCAUAUACCAAAUGCUGAUGUGAUCAGCCUCACAGGAGAUGGCCGUGCAGAUAAGAAGAGCUCACAGGAUUCUGCUGCCCUGUUCUUGCUCUAUGAGCUUCAGCGGCGAGGUACUUUGCAACUCCAGGAGGUGUGAAGGAACGACAACUGAUUGCUUGCCAACCAGUUGCUUGGAAGUUGGAAUAAUAGACCAACCAGUUGCUUGCCACCACUCAGCUUUGUACAUCUUCUCCAGUGUUCACCUUCUGAAUUAUGAUAAGAGGGUACCCAAAGAAUGGAGAACAGCUGACCUGGUUCUGGUGUGUGUCAGUUGUUAUGUGUGUUUGUCCAUAUGUUAUCUGCGUAGAAACUGAAUAAGCCCCCAAAGUUGUUGCUGACGAUAAACACGCAAAUAUCAUGCCCCUGUAGCCUGUAGGUGUUAAACCAAUUGUUCAAGGAUAAAAAGAGAGACCAUUUUCAAAUCAUGUUUCCUUGUUCUAUUAUUACAUAAACAUACCGGACUUUUUUUCUUAUAAAAACUACUCCAGUAAACAUUUGAUCA


Expression Capacity

HE: High-Expressed (TPM > upper quantile); ME: Medium-Expressed (TPM < upper quantile and TPM > lower quantile); LE: Low-Expressed (TPM < lower quantile); NE: Not Expressed.

HEP: High-Expressed Percentage; MEP: Medium-Expressed Percentage; LEP: Low-Expressed Percentage; NEP: Not Expressed Percentage.


Osa-phasi01g0932 is not expressed in all samples, so there is no expression ability

Tissue Specific Expression

cutoff: tau > 0.9 and Average expression in the tissue > 10


Tip: Osa-phasi01g0932 is not a tissue-specific expression ncRNA.

Differential Expression

cutoff: log2(fold change) > 1 or log2(fold change) < -1 and p-adj < 0.01


Num. Condition log2(FoldChange) Padj
Tip: Osa-phasi01g0932 is not a differential expression ncRNA.